Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1026726-20-4

Post Buying Request

1026726-20-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1026726-20-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1026726-20-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,2,6,7,2 and 6 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1026726-20:
(9*1)+(8*0)+(7*2)+(6*6)+(5*7)+(4*2)+(3*6)+(2*2)+(1*0)=124
124 % 10 = 4
So 1026726-20-4 is a valid CAS Registry Number.

1026726-20-4Downstream Products

1026726-20-4Relevant articles and documents

Discovery of a simple picomolar inhibitor of cholesteryl ester transfer protein

Reinhard, Emily J.,Wang, Jane L.,Durley, Richard C.,Fobian, Yvette M.,Grapperhaus, Margaret L.,Hickory, Brian S.,Massa, Mark A.,Norton, Monica B.,Promo, Michele A.,Tollefson, Michael B.,Vernier, William F.,Connolly, Daniel T.,Witherbee, Bryan J.,Melton, Michele A.,Regina, Karen J.,Smith, Mark E.,Sikorski, James A.

, p. 2152 - 2168 (2007/10/03)

A novel series of substituted N-[3-(1,1,2,2-tetrafluoroethoxy)benzyl]-N-(3-phenoxyphenyl)-trifluoro-3- amino-2-propanols is described which potently and reversibly inhibit cholesteryl ester transfer protein (CETP). Starting from the initial lead 1, various substituents were introduced into the 3-phenoxyaniline group to optimize the relative activity for inhibition of the CETP-mediated transfer of [3H]-cholesteryl ester from HDL donor particles to LDL acceptor particles either in buffer or in human serum. The better inhibitors in the buffer assay clustered among compounds in which the phenoxy group was substituted at the 3, 4, or 5 positions. In general, small lipophilic alkyl, haloalkyl, haloalkoxy, and halogen moieties increased potency relative to 1, while analogues containing electron-donating or hydrogen bond accepting groups exhibited lower potency. Compounds with polar or strong electron-withdrawing groups also displayed lower potency. Replacement of the phenoxy ring in 1 with either simple aliphatic or cycloalkyl ethers as well as basic heteroaryloxy groups led to reduced potency. From the better compounds, a representative series 4a-i was prepared as the chirally pure R(+) enantiomers, and from these, the 4-chloro-3-ethylphenoxy analogue was identified as a potent inhibitor of CETP activity in buffer (4a, IC50 0.77 nM, 59 nM in human serum). The simple R(+) enantiomer 4a represents the most potent acyclic CETP inhibitor reported. The chiral synthesis and biochemical characterization of 4a are reported along with its preliminary pharmacological assessment in animals.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1026726-20-4